Nattokinase is a fibrinolytic enzyme extracted from natto, a traditional Japanese fermented soybean food, that can directly break down fibrin, the protein mesh that holds blood clots together. Unlike most dietary supplements, nattokinase has a specific biological mechanism backed by decades of clinical research. A meta-analysis of six randomized controlled trials involving 546 adults found that nattokinase significantly reduced systolic blood pressure by 3.45 millimeters of mercury (mmHg) and diastolic blood pressure by 2.32 mmHg, with over 95% certainty these reductions were real. What Makes Nattokinase Different From Other Supplements? Nattokinase works through multiple pathways that set it apart from typical cardiovascular supplements. The enzyme directly breaks down fibrin into soluble pieces, a rare mechanism among oral supplements. It also activates the body's own natural clot-dissolving system by converting a protein called pro-urokinase into urokinase, which then activates plasminogen into plasmin, your body's primary clot-fighting enzyme. Additionally, nattokinase degrades plasminogen activator inhibitor-1 (PAI-1), a protein that normally blocks clot breakdown, essentially removing the brakes on your body's natural fibrinolytic capacity. You might wonder why people don't just eat natto instead of taking supplements. There are practical reasons. Whole natto contains vitamin K2, which promotes blood clotting, the opposite of what nattokinase does. For people taking blood-thinning medications like warfarin, the vitamin K2 in natto can reduce the drug's effectiveness. Nattokinase supplements with NSK-SD certification have the vitamin K2 removed, making them safer for anticoagulant users. Supplements also provide standardized dosing in fibrinolytic units (FU), while the nattokinase content of natto varies depending on how it's prepared and fermented. How Strong Is the Blood Pressure Evidence? The blood pressure reduction is the most robustly supported benefit of nattokinase supplementation. Two landmark trials anchor this evidence. A randomized controlled trial of 86 Korean adults with pre-hypertension or stage 1 hypertension found that 2,000 FU per day of nattokinase for eight weeks produced significant reductions in both systolic and diastolic blood pressure compared to placebo. A multicenter North American trial confirmed these findings and also demonstrated reduced von Willebrand factor, a cardiovascular risk marker. It's important to understand what these reductions mean in practical terms. A 3 to 5 millimeter of mercury drop is modest, but it's clinically meaningful for population-level cardiovascular risk reduction. This is not a replacement for blood pressure medications prescribed by your doctor, but rather a potential complementary approach. The enzyme also inhibits platelet aggregation, the clumping of blood cells that can contribute to clot formation, without significantly affecting standard blood clotting tests. How to Use Nattokinase Safely and Effectively - Standard Dosage: The Japan Nattokinase Association recommends a minimum of 2,000 FU daily, with clinical trials typically using 2,000 to 4,000 FU per day for cardiovascular support. - Medication Interactions: Nattokinase interacts with blood-thinning medications including warfarin and aspirin, so medical consultation is essential before use if you take anticoagulants or any blood-thinning drugs. - Quality Certification: Look for NSK-SD certification on supplements, which ensures vitamin K2 has been removed and the enzyme activity is standardized, meeting Japanese quality standards with no direct international equivalent. - Timeline for Results: Clinical trials typically ran for eight weeks, suggesting this is a reasonable timeframe to assess whether nattokinase is working for you, though individual responses vary. The safety margin for nattokinase is reported to be three times higher than tPA (tissue plasminogen activator), a powerful intravenous clot-dissolving medication used in emergency settings. However, this comparison illustrates the enzyme's pharmacological profile rather than a recommendation to substitute nattokinase for prescribed medications. What About Other Health Claims? Beyond blood pressure reduction, nattokinase demonstrates anti-inflammatory effects in animal models, and preclinical studies suggest it may influence lipid metabolism. However, these secondary mechanisms are less well-established than the fibrinolytic activity and should be considered supporting evidence rather than primary benefits. The online claims about nattokinase range from dissolving blood clots to protecting your brain, but the clinical evidence is strongest for blood pressure reduction and fibrinolytic activity. One important gap in the research: no head-to-head studies have directly compared the bioavailability of nattokinase from supplements versus natto food. The assumption that supplements deliver equivalent or better absorption is reasonable but not definitively proven by clinical trials. If you're considering nattokinase for cardiovascular support, the evidence suggests modest but meaningful blood pressure reductions are possible. However, this should complement, not replace, your doctor's recommendations for managing blood pressure and cardiovascular health. Always consult with your healthcare provider before starting any new supplement, especially if you take blood-thinning medications or have existing cardiovascular conditions.
